Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Diabetes: Valeritas registers $90m IPO
Valeritas registered for an initial public offering worth up to $90 million for its V-Go insulin delivery system.
Bridgewater, N.J.-based Valeritas said it plans to list on the NASDAQ exchange under the “VLRX” symbol. Read more
2. Smith & Nephew gets in on Michelson Diagnostics Series B round
Smith & Nephew put down the cornerstone in the 1st tranche of Michelson Diagnostics’ $3.8 million (£2.5 million) Series B round for its skin cancer detection device.
Kent, U.K.-based Michelson’s VivoSight device uses optical coherence tomography to generate images of tissues and vasculature beneath the skin. Smith & Nephew contributed $2.3 million (£1.5 million) to the Series B tranche, which also included new investor the Kent County Council, and existing backers. Read more
1. The telltale heart device
A pacemaker made by St. Jude Medical helped reportedly helped clear a son accused of murdering his father by establishing a time death that was covered by the son’s alibi.
Claudio Cara, 56, was stabbed 5 times in the house he shared with his son, Frank Cara, according to the Toronto Star. Although the younger Cara had an alibi – he was visiting family at the time – he still spent 10 months in jail as his father’s accused killer as Canadian police built their case against him. Read more
